Health Canada - Government of Canada
Skip to left navigationSkip over navigation bars to content
Drugs and Health Products
Contact
Policy Bureau Enquiries
This document is also available in PDF format
[sacbb_ccsbb_m_e.pdf]
Pages: 2, Size: 55 K, Date: 2003-09-25

SCIENTIFIC ADVISORY COMMITTEE ON BIOAVAILABILITY AND BIOEQUIVALENCE

MEMBERSHIP LIST

(ad hoc members in italics)

Jake Thiessen, Ph.D. (Chair)
Faculty of Pharmacy
University of Toronto

Allan Donner, Ph.D.
Department of Epidemiology & Biostatistics
University of Western Ontario

Robert Herman, M.D.
Division of General Internal Medicine
University of Calgary

Fakhreddin Jamali, Ph.D.
Faculty of Pharmacy & Pharmaceutical Sciences
University of Alberta

Rama Nair, Ph.D.
Director of the Graduate Program
Department of Epidemiology and Community Medicine
University of Ottawa

Eugenia Palylyk-Colwell, Ph.D.
Clinical Drug Services and Evaluation
Alberta Blue Cross

William Racz, Ph.D.
Queen's University
Department of Pharmacology and Toxicology

Ken Renton, Ph.D.
Faculty of Pharmacology
Dalhousie University, Halifax

Wayne Riggs, Ph.D.
Associate Professor
Faculty of Pharmaceutical Sciences
University of British Columbia

Daniel Sitar, Ph.D.
Clinical Pharmacology Section
University of Manitoba

France Varin, Ph.D.
Professeure titulaire
Faculté de pharmacie
Université de Montréal

Scott Walker, M.Sc.
Pharmacy Department
Sunnybrook Health Science Centre

Last Updated: 2003-09-25 Top